Effectiveness of VistaO2 Device in Screening of Sleep Apnea/Hypopnea

Status Completed

Clinical Trial Summary

The high prevalence (9% in men and 4% in women) of sleep apnea / hypopnea syndrome (SAHS) in adults is now well documented as well as its cardiovascular repercussions. Previous studies showed a conclusive link between SAHS and severe cardiovascular diseases such as hypertension, myocardial infarction, heart failure and stroke.Then, SAHS is a public health issue in adults.

In this context, early detection of such a disease is crucial if the management is tailored to the patient, the practitioner's choice of therapy moving towards continuous positive airway pressure (CPAP) or mandibular advancement device. The detection is based on full nocturnal polysomnography or polygraphic recordings. Polysomnography remains the gold standard but it is a time consuming and costly examination. Polygraphic recording is a test that allows simplified the diagnosis of severe patients, but may not be sufficient for mild form of SAHS. Thus, the SAHS is a pathology under-diagnosed and under-treated. The validation of a technique for identifying patients most at risk to either limit the number of polysomnographic examination is requested.

Clinical Trial Description

In this perspective, the development of a product screening sleep related breathing disorders for physicians, cardiologists, internists (not specialized sleep experts) would fill this need. It allows for a reliable first screening for their patients in parallel with a routine cardiological examination. Imposing a minimal human and material, the ECG Holter recorder "VistaO2" (NOVACOR, Rueil-Malmaison, France) is a device designed to meet these requirements. This device fits into the daily management of patients with cardiac arrhythmias or sinus/atrioventricular conduction disorders, and of patients suffering myocardial infarction (arrhythmic risk stratification, detection of silent myocardial ischemia).

Analysis of heart rate variability (HRV) has already shown interest in screening SAHS. We therefore wish to evaluate the performance of the analysis of data from the screening tool VistaO2 face what the gold standard synchronized polysomnography. ;

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01135303
Study type	Interventional
Source	Centre Hospitalier Universitaire de Saint Etienne
Contact
Status	Completed
Phase	N/A
Start date	February 2009
Completion date	January 2011

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05477719` - Effect of Compression Stockings on the Number of Apneas/Hypopneas Per Hour of Sleep in Patients With Syndrome Obstructive Sleep Apnea/Hypopnea as Compared to no Treatment	N/A
Completed	`NCT04979234` - A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome	N/A
Terminated	`NCT02735694` - Cycloserine in the Treatment of Sleep Apnea	Phase 1
Active, not recruiting	`NCT02470182` - Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors
Completed	`NCT02088723` - Testing the Elevation as Sleep Apnea Treatment	N/A
Completed	`NCT01457014` - Sleep Disordered Breathing and Chronic Pain	N/A
Completed	`NCT00976417` - Mechanisms of Action of Adaptive Servoventilation	N/A
Completed	`NCT00860743` - Respiratory and Autonomic Plasticity Following Intermittent Hypoxia	Early Phase 1
Active, not recruiting	`NCT00371293` - The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease	N/A
Completed	`NCT00607893` - Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea	N/A
Completed	`NCT00083798` - Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland	N/A
Completed	`NCT00089752` - Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea	N/A
Completed	`NCT00070681` - Outcomes of Sleep Disorders in Older Men	Phase 3
Completed	`NCT00051363` - Apnea Positive Pressure Long-Term Efficacy Study	Phase 3
Completed	`NCT00046670` - Sleep Disordered Breathing, APOE, and Lipid Metabolism	N/A
Completed	`NCT00031239` - Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEAD	N/A
Completed	`NCT00006323` - Neurobehavioral Consequences of Sleep Apnea in Children	N/A
Terminated	`NCT00006321` - Neurocognitive Function in Snoring Children	N/A
Completed	`NCT00005511` - SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea	N/A
Completed	`NCT00005275` - Sleep Heart Health Study (SHHS) Data Coordinating Center	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effectiveness of VistaO2 Device in Screening of Sleep Apnea/Hypopnea Syndrome — VISTAO2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms